Categories
Announcements COVID-19 Opportunities Find Funding

On January 30th, 2020, the WHO declared the recent outbreak of coronavirus disease 2019 (COVID-19), a public health emergency of international concern. It declared that there is an urgent need to improve our understanding of the newly identified virus and its possible future evolution as well as to contain the spread; to develop precise diagnostics and treatment, and to improve the public health response and patient care.

The SLS and the SwissFEL provide unique characterisation techniques to efficiently and promptly support these needs. PSI are opening a “PRIORITY COVID-19 Call” for short proposals and quick peer review to enable rapid access to beamtime. Research proposals shall have the potential to effectively contribute to the understanding of the virus and/or to improve the clinical or public health response and patient care. This “PRIORITY COVID-19 Call” is explicitly for projects requiring a rapid access to beamtime within the next months. For other projects we are referring to our regular calls.

Deadline: September 9, 2020

More information.

Categories
Announcements COVID-19 Opportunities Find Funding

In light of the emergence and spread of the coronavirus disease 2019 (COVID-19) in the United States and abroad, the National Science Foundation (NSF) is accepting proposals to conduct non-medical, non-clinical-care research that can be used immediately to explore how to model and understand the spread of COVID-19, to inform and educate about the science of virus transmission and prevention, and to encourage the development of processes and actions to address this global challenge.

More information.

Categories
Announcements COVID-19 Opportunities Find Funding

Contracts Management & Acquisition (CMA)on behalf of the Office of Biomedical Advanced Research and Development Authority (BARDA) solicits proposals for the advanced research and development of medical countermeasures (MCM) for chemical, biological, radiological and nuclear (CBRN) agents, pandemic influenza, and emerging infectious diseases that threaten the U.S. civilian population. Due to the COVID-19 response, any white papers or full proposals submissions, other than those that are in support of COVID-19, will be put into a queue.  

Deadlines: A Quad Chart and White Paper may be submitted on any day during the open period of the BAA. Submission deadlines are as follows:

  • April 30, 2020
  • July 31, 2020
  • October 31, 2020

More information.

Categories
Announcements COVID-19 Opportunities

Defense Logistics Agency (DLA) Troop Support Clothing & Textiles Directorate is conducting market research to determine industry capabilities for providing Personal Protective Equipment (PPE) against viral contamination, specifically COVID-19. This is a Request for Information only and not a solicitation for award.

Deadline: Initial responses are requested by 5:00 PM, Tuesday, 24 March 2020. However, DLA will accept any and all responses received after this date and time for any ongoing requirements.

More information.

Categories
Announcements COVID-19 Opportunities Find Funding

A collection of notices and opportunities from NIH regarding COVID-19 research. More information.

TitleNotice NumberOrganization(s)Release
Date
Expiration
Date
Activity
Code(s)
Notice of Special Interest (NOSI): Availability of Emergency Awards for Limited Clinical Trials to Evaluate Therapeutic and Vaccine Candidates Against SARS-CoV-2NOT-AI-20-065NIAIDAug 13, 2020Sep 1, 2021U01
Notice of Special Interest (NOSI): Simulation Modeling and Systems Science to Address Health DisparitiesNOT-MD-20-025NIMHDNCINIDANLMODPOBSSRNIMHNIAMSAug 13, 2020May 8, 2023R01
Emergency Awards: RADx-rad Predicting Viral-Associated Inflammatory Disease Severity in Children with Laboratory Diagnostics and Artificial Intelligence (PreVAIL kIds) (R61/R33 Clinical Trial Optional)RFA-OD-20-023NIHFICNCATSNHLBINIAIDNIAMSNICHDNIDANIMHDAug 6, 2020Oct 1, 2020R61/R33
Emergency Awards: Chemosensory Testing as a COVID-19 Screening Tool (U01 Clinical Trial Optional)RFA-OD-20-022NIHNIANIDCDORWHNICHDNLMNINRNINDSNIDCRAug 6, 2020Sep 16, 2020U01
Emergency Awards RADx-RAD: Novel Biosensing for Screening, Diagnosis and Monitoring of COVID-19 From Skin and The Oral Cavity (Fast-Track STTR Clinical Trial Not Allowed)RFA-OD-20-021NIHNIAAANIAMSNICHDNIBIBNIMHDNLMNCATSNHLBINIDCRAug 6, 2020Sep 19, 2020R42
Emergency Awards RADx-RAD: Novel Biosensing for Screening, Diagnosis and Monitoring of COVID-19 From Skin and The Oral Cavity (R44 Clinical Trial Not Allowed)RFA-OD-20-020NIHNIAAANIAMSNICHDNIBIBNIMHDNLMNCATSNHLBINIDCRAug 6, 2020Sep 19, 2020R44
Emergency Awards: RADx-rad Data Coordination Center (DCC) (U24 Clinical Trial Not Allowed)RFA-OD-20-019NIHNIAAANIANCCIHNIDCDNIDDKNIEHSNIGMSNICHDNIMHDNLMNINRNCATSOBSSRNHLBINIDCRNIDAAug 6, 2020Oct 1, 2020U24
Emergency Awards: Exosome-based Non-traditional Technologies Towards Multi-Parametric and Integrated Approaches for SARS-CoV-2 (U18 Clinical Trial Not Allowed)RFA-OD-20-018NIHNIANCIRMNCATSNHLBINIDCRNIDANHGRIAug 6, 2020Sep 19, 2020U18
Emergency Awards: Exosome-based Non-traditional Technologies Towards Multi-Parametric and Integrated Approaches for SARS-CoV-2 (U18 Clinical Trial Not Allowed)RFA-OD-20-018NIHNIANCIRMNCATSNHLBINIDCRNIDANHGRIAug 6, 2020Sep 19, 2020U18
Emergency Awards RADx-RAD: Screening for COVID-19 by Electronic-Nose Technology (SCENT) (U18 Clinical Trial Not Allowed)RFA-OD-20-017NIHNIAAANIANIAMSNICHDNIBIBNIMHDNLMNCATSNHLBINIDCRAug 6, 2020Sep 19, 2020U18
Emergency Awards: RADx-RAD Multimodal COVID-19 surveillance methods for high risk clustered populations (R01 Clinical Trial Optional)RFA-OD-20-016NIHNIAAANIDDKNIGMSNIMHDNLMNINROBSSRNIDCRNIDAAug 6, 2020Oct 1, 2020R01
Emergency Awards: RADx-rad Wastewater Detection of SARS-COV-2 (COVID-19) (U01 – Clinical Trials Not Allowed)RFA-OD-20-015NIHNIEHSNIGMSNLMNIDAAug 6, 2020Sep 16, 2020U01
Emergency Awards: Automatic Detection and Tracing of SARS-CoV-2 (U01 Clinical Trial Not Allowed)RFA-OD-20-014NIHNIAAANIANCCIHNCINICHDAug 6, 2020Sep 16, 2020U01
Notice of Special Interest (NOSI): Availability of Emergency Competitive Revisions for Chemosensory Testing as a COVID-19 Screening ToolNOT-OD-20-152NIHNIANIDCDORWHNICHDNINRNINDSNIDCRAug 6, 2020Sep 16, 2020333
Urgent Phase I/II Clinical Trials to Repurpose Existing Therapeutic Agents to Treat COVID-19 Sequelae (U01 Clinical Trial Required)RFA-TR-20-003NCATSAug 5, 2020Jan 24, 2021U01
Limited Competition Emergency Awards: Shared Personal Protective Equipment Resources for COVID-19 Related Vaccine and Treatment Clinical Trials and Clinical Studies (S10 Clinical Trial Not Allowed)PAR-20-256NIAIDJul 13, 2020Jul 8, 2021S10
Mechanistic Studies of the Interaction between SARS-CoV-2/COVID-19 and Diseases and Organ Systems of Interest to NIDDK (R01 Clinical Trial Optional)RFA-DK-20-021NIDDKJul 10, 2020Dec 17, 2020R01
Notice of Special Interest (NOSI) regarding the Availability of Emergency Competitive Revisions for Select Research Activities related to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19)NOT-AI-20-059NIAIDJul 6, 2020Jul 2, 2021333
Digital Healthcare Interventions to Address the Secondary Health Effects Related to Social, Behavioral, and Economic Impact of COVID-19 (R01 – Clinical Trial Optional)PAR-20-243NIMHNCCIHSGMROODPNIDCDOBSSRNEINIDANIANIAAANICHDNCATSORWHNIDCRNINRNIMHDJun 25, 2020Mar 3, 2021R01
Notice of Special Interest (NOSI) regarding the Availability of Urgent Competitive Revisions and Administrative Supplements for Research on Coronavirus Disease 2019 (COVID-19) in Individuals with Down Syndrome for the INCLUDE ProjectNOT-OD-20-129NIHNCINHGRINCCIHNINDSORIPNIMHDNIANIDCRNIAIDNIAMSNIEHSNCATSNIDCDNICHDNIDDKNHLBIJun 25, 2020Jul 13, 2021333
Community Interventions to Address the Consequences of the COVID-19 Pandemic among Health Disparity and Vulnerable Populations (R01- Clinical Trial Optional)PAR-20-237NIMHDNIDCDNIMHODPNINRNIASGMRONIDDKNIEHSNICHDNCATSORWHNIAAANCCIHNIDANEINIDCRJun 17, 2020Dec 2, 2020R01
Notice of Special Interest (NOSI): New Administrative Supplement Applications to UL1 and U24 CTSA Awards to Address COVID-19 Public Heath NeedNOT-TR-20-029NCATSJun 15, 2020Nov 11, 2020333
NIA Multi-site COVID-19 Related Clinical Trial Implementation Grant on Aging-Related Topics in at-risk Older Adult Populations (R01 Clinical Trial Required)PAR-20-234NIAJun 15, 2020Feb 2, 2021R01
Notice of Special Interest (NOSI): Emergency Competitive Revisions for Community-Engaged Research on COVID-19 Testing among Underserved and/or Vulnerable PopulationsNOT-OD-20-120NIHNIAIDNIBIBNIDCRNIMHDNICHDNIAMSFICNCINCATSNCCIHNEINHLBINIDDKNIEHSNIGMSNHGRINIMHNINDSNINRNIAAANIANIDCDNIDAORWHOBSSRODPNLMSGMROTHROJun 12, 2020Sep 9, 2020333
Notice of Special Interest (NOSI): Emergency Competitive Revisions for Social, Ethical, and Behavioral Implications (SEBI) Research on COVID-19 Testing among Underserved and/or Vulnerable PopulationsNOT-OD-20-119NIHNICHDFICNCINCATSNCCIHNEINHLBINIAIDNIAMSNIBIBNIDCRNIDDKNIEHSNIGMSNHGRINIMHNINDSNINRNIANIAAANIDANIMHDORWHODPNLMSGMROTHRONIDCDOBSSRJun 12, 2020Sep 9, 2020333
Notice of Special Interest (NOSI): Competitive and Administrative Supplements for Community Interventions to Reduce the Impact of COVID-19 on Health Disparity and Other Vulnerable PopulationsNOT-MD-20-022NIMHDNIAAANCCIHNIDCRNCATSNIEHSORWHNIDAOBSSRNIDCDSGMRONICHDODPNIMHNHLBINIANEINIDDKJun 5, 2020Dec 30, 2020333
Notice of Special Interest (NOSI): Digital Healthcare Interventions to Address the Secondary Health Effects Related to Social, Behavioral, and Economic Impact of COVID-19NOT-MH-20-053NIMHNICHDORWHNIDCRNCATSNIDAOBSSRNCCIHNINRODPNIDCDNHLBINIANEINIAAANIMHDSGMRONIDDKJun 5, 2020Dec 30, 2020333
Notice of Special Interest (NOSI): NIDCD is Interested in Supporting Research on the Impact of COVID-19 on Mission Specific Sensory and Communication DisordersNOT-DC-20-008NIDCDJun 4, 2020Sep 8, 2022R01, R21, R41/R42, R43/R44
NIH Directors Emergency Transformative Research Awards (R01 Clinical Trial Optional)RFA-RM-20-020RMODMay 21, 2020Oct 1, 2020R01
NIH Directors Emergency Early Independence Awards (DP5 Clinical Trial Optional)RFA-RM-20-021RMODMay 21, 2020Sep 5, 2020DP5
Notice of Special Interest (NOSI): Select Research Areas for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19)NOT-AI-20-051NIAIDMay 19, 2020Sep 8, 2021R03, R43/R44, R41/R42
Notice of Special Interest (NOSI):? Availability of Urgent Competitive Revisions and Administrative Supplements for Coronavirus Disease 2019 (COVID-19) Research within the Mission of NIDCRNOT-DE-20-022NIDCRORWHMay 5, 2020Nov 3, 2020333
Notice of Special Interest (NOSI): Infrastructure Access for Research on Coronavirus Disease 2019 (COVID-19) Conducted in the National Dental Practice-Based Research NetworkNOT-DE-20-023NIDCRMay 1, 2020Nov 3, 2020X01
Notice of Special Interest (NOSI): Availability of Urgent Competitive Revisions and Administrative Supplements For Research on Biological Effects of the 2019 Novel Coronavirus on the Nervous SystemNOT-NS-20-051NINDSApr 30, 2020Apr 15, 2021333
Notice of Special Interest (NOSI): Availability of Emergency Competitive Revisions on Coronavirus Disease 2019 (COVID-19) for Currently Active NHLBI Phase I-III Clinical TrialsNOT-HL-20-782NHLBIApr 27, 2020Oct 6, 2020333
Notice of Special Interest (NOSI): Availability of Emergency Competitive Revisions and Administrative Supplements to Clinical and Translational Science Award (CTSA) Program Awards to Address 2019 Novel Coronavirus Disease (COVID-19) Public Health NeedsNOT-TR-20-028NCATSApr 23, 2020Nov 11, 2020333
Notice of Special Interest: Availability of Administrative Supplements and Competitive Revision Supplements on Coronavirus Disease 2019 (COVID-19) within the Mission of NIAAANOT-AA-20-011NIAAAApr 16, 2020Apr 16, 2021333
Notice of Special Interest (NOSI) regarding the Availability of Administrative Supplements and Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus and the Behavioral and Social SciencesNOT-OD-20-097OBSSRNCCIHNCINHGRINHLBINIANIAAANICHDNIDDKNIEHSNINRODPORWHApr 13, 2020Apr 1, 2021333
Notice of Special Interest (NOSI): NIEHS Support for Understanding the Impact of Environmental Exposures on Coronavirus Disease 2019 (COVID-19)NOT-ES-20-020NIEHSApr 10, 2020May 4, 2021333, R21
Notice of Special Interest (NOSI): Small Business Research and Development of Biomedical Technologies for Coronavirus Disease 2019 (COVID-19)NOT-EB-20-006NIBIBApr 10, 2020Sep 6, 2020R41/R42, R43/R44
Notice of Special Interest (NOSI): Competitive and Administrative Supplements for the Impact of COVID-19 Outbreak on Minority Health and Health DisparitiesNOT-MD-20-019NIMHDNIANIAAANIMHODPApr 9, 2020May 1, 2021333
Notice of Special Interest (NOSI) regarding the Availability of Emergency Competitive Revisions to Existing NIH Grants and Cooperative Agreements for Tissue Chips Research on the 2019 Novel CoronavirusNOT-TR-20-017NCATSApr 9, 2020Jan 26, 2022333
Notice of Special Interest (NOSI) regarding the Availability of Administrative Supplements and Urgent Competitive Revisions for Mental Health Research on the 2019 Novel CoronavirusNOT-MH-20-047NIMHNIAODPNIAAANIMHDApr 9, 2020Apr 16, 2021333
Notice of Special Interest (NOSI) regarding the Availability of Administrative Supplements for Tissue Chips Research on the 2019 Novel CoronavirusNOT-TR-20-016NCATSApr 9, 2020Jan 26, 2022333
Notice of Special Interest (NOSI): Availability of Administrative Supplements and Urgent Competitive Revisions for Research on Stress Management in Relation to Coronavirus Disease 2019 (COVID-19)NOT-AT-20-011NCCIHNIANIAAAODPApr 9, 2020Oct 7, 2020333
Notice of Special Interest (NOSI): NIEHS Support for Understanding the Impact of Environmental Exposures on Coronavirus Disease 2019 (COVID-19)NOT-ES-20-015NIEHSApr 8, 2020May 4, 2021333, R21
Notice of Special Interest (NOSI): NIA Availability of Administrative Supplements and Revision Supplements on Coronavirus Disease 2019 (COVID-19)NOT-AG-20-022NIANIMHApr 2, 2020May 1, 2021333
Notice of Special Interest (NOSI): Repurposing Existing Therapeutics to Address the 2019 Novel Coronavirus Disease (COVID-19)NOT-TR-20-012NCATSMar 27, 2020Oct 17, 2020UH2, U01, U34
RESCINDED – Notice of Special Interest (NOSI): Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19)NOT-AI-20-031NIAIDMar 27, 2020Apr 5, 2021R03, R21, 333, R01, R43/R44, R41/R42
Notice of Special Interest (NOSI) regarding the Availability of Urgent Competitive Revisions for Research on Coronavirus Disease 2019 (COVID-19) and the Causative Virus SARS-CoV-2NOT-GM-20-025NIGMSMar 25, 2020Feb 6, 2021333
Notice of Special Interest (NOSI): Clinical and Translational Science Award (CTSA) Program Applications to Address 2019 Novel Coronavirus (COVID-19) Public Heath NeedNOT-TR-20-011NCATSMar 24, 2020Jul 10, 2021333, U01, R21, U54
Notice of Special Interest (NOSI) regarding the Availability of Administrative Supplements and Urgent Competitive Revisions for Research on the 2019 Novel CoronavirusNOT-DA-20-047NIDAMar 19, 2020Mar 31, 2021333
Emergency Competitive Revision to Existing NIH Awards (Emergency Supplement – Clinical Trial Optional)PA-20-135NIHNCATSNCCIHNCINHGRINIANIAAANIAIDNIAMSNIBIBNICHDNIDCDNIDDKNIEHSNIGMSNIMHNIMHDNINRNLMORWHOSCMar 10, 2020Sep 8, 2025333
Categories
Announcements COVID-19 Opportunities Find Funding

This call aims to strengthen the evidence base to better prevent and control coronavirus (COVID-19) epidemics and to increase research and response capacity. It’s part of an existing partnership between Wellcome and the UK Department for International Development (DFID) through the Joint Initiative on Research in Epidemic Preparedness and Response to help low- and middle-income countries prepare for and tackle epidemics. The scope of this call is broad.

Deadline: There are no deadlines. Expressions of interest should be submitted as soon as possible. Wellcome may close this call to new applicants at any time.

More information.